As the premier, multidisciplinary journal covering all aspects of gene therapy, this journal publishes important advances in DNA, RNA, cell, and immune therapies, validating the latest advances in research and new technologies. Established in 1990, the journal provides a prestigious forum for publishing scientific and clinical research, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
